$0.93
arrow_drop_up0.96%Key Stats | |
---|---|
Open | $0.95 |
Prev. Close | $0.96 |
EPS | -0.28 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $73.68M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 0.93 | 0.95 |
52 Week Range | 0.85 | 2.30 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -0.28 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Cancer Research Sees Major Boost as New Breakthroughs Emerge from Key Oncology Players
Oncolytics Biotech (ONCY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Gilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
Bristol-Myers' (BMY) to Report Q1 Earnings: What You Should Know
Novartis (NVS) to Report Q1 Earnings: What to Expect?
After Plunging -29.54% in 4 Weeks, Here's Why the Trend Might Reverse for Oncolytics Biotech Inc. (ONCY)